Personalis at IO Combinations 360: October 1-2, 2020


Travis Yates PhD
Field Applications Scientist

Thursday, October 1 | 1:10 PM Eastern

Comprehensive immunogenomics to enable composite biomarkers for immunotherapy response using a sample sparing approach

  • Predicting patient response to immunotherapies requires a robust approach to tumor immunogenomics
  • By combining highly sensitive, exome-scale DNA and RNA sequencing with advanced analytics, ImmunoID NeXT provides a broad view of the tumor and the immune-related components of the tumor microenvironment from a single sample preparation
  • In this presentation, we’ll discuss the benefits of this unique, innovative design for immuno-oncology translational research including mastering challenging samples, utilizing optimized algorithms, and obtaining accurate genomic data for identifying novel predictors of response
  • A case study from a cohort of metastatic melanoma patients treated with immune checkpoint blockade will highlight the analytical capabilities provided by this immunogenomic profiling solution for understanding mechanisms of tumor evasion and creating composite biomarkers

Connect with us at IO Combinations 360 2020